Michael J. Fox Foundation for Parkinson's Research: Repositioning Drugs - Pre-Proposals

The program is to support the repositioning of clinically safe compounds from other indications to PD research. Projects appropriate for this program will test drugs that have already been proven safe in a clinical trial for an unrelated indication or FDA-approved drugs, to determine whether the therapeutics are efficacious in treating PD. MJFF will commit up to $3 million to fund applications submitted in response to this RFA. MJFF intends to fund multiple proposals as part of this initiative although it would consider funding a single high-impact proposal if appropriate. Up to 3 years.